GlySens: GlySens Incorporated Closes Incremental $15 Million Financing
Proceeds from the financing will support ongoing clinical trials and development programs supporting the Company's fully implanted, long-term CGM systems and additionally, enable first-in-man studies of the third-generation system. Source
Read full article »
GlySens is a California-based medical device company that designs and develops glucose monitoring systems for diabetes patients.
Read more